Latest Commercialisation News

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Radiopharm Theranostics has reached the halfway mark in enrolling patients for its Phase 2b trial of RAD101, a novel imaging agent targeting brain metastases. Early data suggest RAD101 may outperform MRI in distinguishing tumor recurrence from radiation damage.

Calix Limited has secured a pivotal $35 million joint development agreement with Rio Tinto to advance its Zesty Green Iron Demonstration Plant in Western Australia, backed by a substantial ARENA grant. This collaboration aims to pioneer low-emission steel production using innovative hydrogen and electric heating technology.

Red Metal Limited has achieved a significant metallurgical breakthrough at its Sybella Rare Earth Project, using ion exchange resins to enrich rare earth elements nine times while drastically cutting impurities and costs.

BPM Minerals has confirmed a significant gold system footprint at its Forelands Project in WA, spotlighting the untested Bonnie & Clyde Prospect and gearing up for drilling at Beachcomber.

Australian Bond Exchange narrowed its FY25 loss by 26% through disciplined cost cuts and is advancing its fintech strategy with AI-driven credit tools and tokenised asset ambitions.

Centrepoint Alliance has reported record FY25 financial results, driven by strong organic growth, strategic acquisitions, and early adoption of AI technology. The company’s outlook for FY26 remains positive with increased EBITDA guidance and continued expansion in higher-margin segments.

Coda Minerals reports steady progress in its diamond drilling program at Elizabeth Creek, confirming geological models and underpinning a robust $1.3 billion pre-feasibility study valuation. The ongoing work supports future development with promising upside from current copper and silver prices.

EBR Systems has achieved a major commercial milestone with Medicare reimbursement approvals for its wireless cardiac pacing WiSE CRT System, driving a 201% revenue increase in Q3 2025. The company is advancing its Limited Market Release as it scales adoption in the US.

Kinetiko Energy has raised $3.15 million through a placement led by key South African and Australian investors to fast-track its Project Alpha gas development in South Africa. The capital injection supports drilling and exploration activities aimed at expanding the company’s resource base.

Proteomics International Laboratories has secured a $2.2 million Australian Government R&D tax rebate, reinforcing its financial position as it advances a promising pipeline of diagnostic tests based on its proprietary Promarker® technology.

Carnegie Clean Energy's subsidiary has received a significant milestone payment under the EuropeWave contract, marking progress in deploying its wave energy technology at a key European marine site.